Review: Therapeutic Drug Monitoring in Pediatrics
Potential Benefit of Bayesian Forecasting for Therapeutic Drug Monitoring in Neonates
Clinical Relevance of Therapeutic Drug Monitoring During Pregnancy
Estimation of Fetal Exposure to Drugs of Abuse, Environmental Tobacco Smoke, and Ethanol
HIV Drug Interactions: The Good, the Bad, and the Other
Protein Ubiquitin is an Immunophilin
Factors Associated With Long-Term Renal Allograft Survival
Two-Hour Cyclosporine Concentration Determination: An Appropriate Tool to Monitor Neoral Therapy?
Update on Pharmacokinetic/Pharmacodynamic Studies With FTY720 and Sirolimus
Early Clinical Experience With a Novel Rapamycin Derivative
International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology Working Group on Immunosuppressive Drug Monitoring
Monitoring of Mycophenolic Acid in Clinical Transplantation
Marketed New Antiepileptic Drugs: Are They Better Than Old-Generation Agents?
Challenges in the Clinical Development of New Antiepileptic Drugs
New Antiepileptic Drugs Currently in Clinical Trials: Is There a Strategy in Their Development?
New Antiepileptic Drugs: Review on Drug Interactions
5´-OH-Thalidomide, a Metabolite of Thalidomide, Inhibits Angiogenesis
Polymorphisms of UDP-Glucuronosyltransferase and Pharmacokinetics of Irinotecan
Negative Ion Chemical Ionization Gas Chromatography-Mass Spectrometry and Atmospheric Pressure Chemical Ionization Liquid Chromatography-Mass Spectrometry of Low-Dosed and/or Polar Drugs in Plasma
Is LC-MS Suitable for a Comprehensive Screening of Drugs and Poisons in Clinical Toxicology?
High-Throughput Quantification of Drugs and Their Metabolites in Biosamples by LC-MS/MS and CE-MS/MS: Possibilities and Limitations
Organophosphate Pesticides: Biochemistry and Clinical Toxicology
Recent Advances in the Management of Poisoning
Scoring and Performance of Analysis and Interpretation of Toxicologic Cases Assessed by External Quality Assurance
Evidence in Clinical Toxicology: The Role of Therapeutic Drug Monitoring
Genetic Variation in CYP2A6-Mediated Nicotine Metabolism Alters Smoking Behavior
South Africa: A Toxicologist's Goldmine
Abuse of Performance-Enhancing Drugs in Sport
Working to Recognized Standards: A Prerequisite for Drug Testing in Australia
Substance Abuse Monitoring by the Correctional Service of Canada
International Association of Therapeutic Drug Monitoring and Clinical Toxicology Newsletter